Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsStem CellsTreatment OutcomeMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanGraft vs Host DiseaseCombined Modality TherapyHematologic NeoplasmsBone Marrow TransplantationRemission InductionSalvage TherapyDisease-Free SurvivalRecurrenceCyclophosphamideHodgkin DiseaseHematopoietic Stem Cell MobilizationEtoposideMyeloablative AgonistsLymphoma, Non-HodgkinRetrospective StudiesTransplantationSurvival RateAntigens, CD34CytarabineTissue DonorsHistocompatibility TestingCarmustineBone Marrow PurgingSurvival AnalysisStem Cell NicheWhole-Body IrradiationGraft SurvivalThiotepaTransplantation ChimeraVincristineBusulfanFollow-Up StudiesCell DifferentiationAdult Stem CellsHematopoiesisAmyloidosisHepatic Veno-Occlusive DiseaseImmunocompromised HostImmunosuppressive AgentsPrognosisLymphoma, Mantle-CellEmbryonic Stem CellsMesenchymal Stem Cell TransplantationBoronic AcidsTime FactorsLeukemiaDoxorubicinDexamethasonePyrazinesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic AgentsThalidomideAntineoplastic Agents, AlkylatingGranulocyte Colony-Stimulating FactorLymphoma, T-Cell, PeripheralKidney TransplantationAutograftsBone MarrowBone Marrow CellsCord Blood Stem Cell TransplantationLymphomaCell LineageIfosfamideLeukapheresisLiver TransplantationLeukemia, Myeloid, AcuteFlow CytometryInduction ChemotherapyPluripotent Stem CellsHLA AntigensCell TransplantationPrednisoneMice, Inbred C57BLAnemia, AplasticCells, CulturedPodophyllotoxinPancytopeniaHistocompatibilityNeoplasm, ResidualCytomegalovirus InfectionsLymphoma, Large B-Cell, DiffuseMyelodysplastic SyndromesProspective StudiesMaintenance ChemotherapyMesenchymal Stromal CellsNeural Stem CellsFetal Blood